Robotic surgery is better for bladder cancer patients, according to The Urology Foundation


Robotic surgery has been around for close to 50 years. To be more precise, the first surgical robot, named PUMA 560, was used in a brain biopsy procedure in 1985. 

Since then, robotic surgery has become less linked to Frankenstein and an increasingly accessible solution for surgical care. 

Development in this technology has become the norm when people are admitted for heart, gynaecological and colorectal - bowel! - procedures. However, it has had a delayed entrance into the urology world, particularly for the treatment of bladder cancer. 

This was mostly down to the fact that, although experts were aware of the short-term benefits of robotic surgery, no one had definitive evidence that it was better than open surgery. 

The Urology Foundation set out to prove it with clear evidence. How? With a three-year clinical trial! 

Back in 2019, the not-for-profit received a grant from the Champniss Foundation to start a trial across nine hospitals in the UK. Working with 29 surgeons and 388 patients with non-metastatic bladder cancer, the Urology Foundation set out on a mission to prove that robotic surgery was as effective as anecdotal evidence showed.